Chul Koo Cho

Papers

1

Total Citations

7

H-Index

1

About

Chul Koo Cho is a pioneering researcher in the field of radiation oncology, with a specialized focus on stereotactic radiotherapy for ocular tumors. His key research areas include image-guided robotic radiotherapy, fractionated stereotactic treatment, and the management of uveal melanoma. Cho's major contribution lies in demonstrating the feasibility and efficacy of a three-fraction image-guided robotic stereotactic radiotherapy (fSRT) approach for uveal melanoma, offering a non-invasive alternative to enucleation for patients with medium-sized or large tumors. This work, published in 2009, has garnered 7 citations and represents a significant step forward in organ-preserving cancer therapy. By enrolling patients who declined traditional surgical removal, Cho's study provided critical evidence that fractionated, high-precision radiation can achieve tumor control while minimizing damage to surrounding healthy tissue. His research bridges the gap between advanced radiation technology and clinical oncology, making him a notable figure in the development of less invasive cancer treatments. Cho's work continues to influence the integration of robotic systems in radiotherapy, offering hope for improved quality of life in patients with ocular malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of Image-Guided Robotic Radiotherapy using Three Fractions for Uveal Melanoma
7 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago